title: Chemokines in vascular dysfunction and remodeling.
abstract: Vascular remodeling stands for structural changes of the vessel wall in response to various noxious stimuli, which results in reorganization of the vessel wall architecture. Luminal narrowing because of neointima formation and constrictive remodeling leading to hypoperfusion is the most relevant clinical effect. Smooth muscle cell (SMC) accumulation, inflammatory cell recruitment, and endothelial regeneration are the critical parts in obstructive vascular remodeling. Chemokines and chemokine receptors have a great impact on initiating and progressing neointimal formation by controlling each step of the remodeling process. SDF-1alpha regulates vascular repair by CXCR4-dependent smooth muscle progenitor cell recruitment, which contributes to the maladaptive response to injury. The three distinct chemokine-chemokine receptor pairs MCP-1/CCR2, RANTES/CCR5, and Fractalkine/CX(3)CR1 direct lesional leukocyte infiltration. In addition MCP-1/CCR2 and Fractalkine/CX(3)CR1 increase neointimal SMC expansion. In contrast, KC/Gro-alpha supports endothelial recovery through CXCR2, which attenuates neointima formation. These findings highlight the importance to characterize specific functions of the chemokine network to enable therapeutic intervention.
authors.affiliation: Cardiology Unit, Medizinische Poliklinik, University of Munich, Medical Policlinic-City Center Campus, University of Munich, Munich, Germany. andreas.schober@med.uni-muenchen.de
authors.forename: Andreas
authors.initials: A
authors.lastname: Schober
mesh_terms: D000818:Animals; D001808:Blood Vessels / Q000276:immunology* / Q000473:pathology; D049109:Cell Proliferation; D018932:Chemokine CCL2 / Q000378:metabolism; D018946:Chemokine CCL5 / Q000378:metabolism; D054428:Chemokine CX3CL1 / Q000378:metabolism; D054377:Chemokine CXCL12 / Q000378:metabolism; D018925:Chemokines / Q000378:metabolism*; D002633:Chemotaxis; D042783:Endothelial Cells / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000276:immunology* / Q000473:pathology; D007962:Leukocytes / Q000276:immunology; D032389:Myocytes, Smooth Muscle / Q000276:immunology; D054390:Receptors, CCR2 / Q000378:metabolism; D019707:Receptors, Chemokine / Q000378:metabolism*; D013234:Stem Cells / Q000276:immunology; D014652:Vascular Diseases / Q000276:immunology* / Q000473:pathology
chemical_list: D018932:Chemokine CCL2; D018946:Chemokine CCL5; D054428:Chemokine CX3CL1; D054377:Chemokine CXCL12; D018925:Chemokines; D054390:Receptors, CCR2; D019707:Receptors, Chemokine